You have 9 free searches left this month | for more free features.

DOAC

Showing 1 - 25 of 167

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

4-Factor PCC in DOAC-associated Intracranial Hemorrhage

Recruiting
  • Intracranial Hemorrhage
  • Use of fixed-dosed 4F-PCC
  • Dallas, Texas
    Methodist Dallas Medical Center
Oct 17, 2023

Atrial Fibrillation Trial in United States (AFSW Guided DOAC, Continuous DOAC therapy)

Not yet recruiting
  • Atrial Fibrillation
  • AFSW Guided DOAC
  • Continuous DOAC therapy
  • (no location specified)
Apr 19, 2023

Liver Cirrhosis Trial (Apixaban 5 MG [Eliquis], Edoxaban 60 MG [Lixiana])

Not yet recruiting
  • Liver Cirrhosis
  • Apixaban 5 MG [Eliquis]
  • Edoxaban 60 MG [Lixiana]
  • (no location specified)
May 19, 2023

Determining Clinical Relevance of Interaction Between

Recruiting
  • Drug-drug Interaction
  • Blood sampling - Pharmacokinetic assessment
  • Nijmegen, Netherlands
  • +2 more
Oct 26, 2022

Ischemic Stroke, Atrial Fibrillation Trial (Left atrial appendage Occlusion and 3 months of Clopidogrel, DOAC)

Not yet recruiting
  • Ischemic Stroke
  • Atrial Fibrillation
  • Left atrial appendage Occlusion and 3 months of Clopidogrel
  • DOAC
  • (no location specified)
Jul 27, 2023

Venous Thrombosis, Tumors, Anticoagulants Trial in Kyoto (Long DOAC, Short DOAC)

Recruiting
  • Venous Thrombosis
  • +2 more
  • Long DOAC
  • Short DOAC
  • Kyoto, Japan
    Department of Cardiovascular Medicine, Kyoto University Graduate
Mar 29, 2022

DOAC in Chinese Patients With Atrial Fibrillation

Recruiting
  • Atrial Fibrillation
  • +6 more
  • Blood Tests
  • Hong Kong, Hong Kong
    Chinese University of Hong Kong
Oct 11, 2022

Bleeding Post Cardiac Surgery, Indication for Anticoagulation Trial in Hamilton (DOAC, VKA)

Recruiting
  • Bleeding Post Cardiac Surgery
  • Indication for Anticoagulation
  • Hamilton, Ontario, Canada
    Hamilton General Hospital
Oct 31, 2022

GastroIntestinal Bleeding, Anticoagulant-induced Bleeding Trial in Ottawa (Restart DOAC within 7 days of clinical hemostasis

Not yet recruiting
  • GastroIntestinal Bleeding
  • Anticoagulant-induced Bleeding
  • Restart DOAC within 7 days of clinical hemostasis after GI bleeding
  • Restart DOAC between 7 to 14 days of clinical hemostasis after GI bleeding
  • Ottawa, Ontario, Canada
    Ottawa Hospital Research Institute
Mar 21, 2022

Atrial Fibrillation, Coronary Artery Disease, Anticoagulants Trial (Uninterrupted NOAC use, Interrupted NOAC use)

Not yet recruiting
  • Atrial Fibrillation
  • +2 more
  • Uninterrupted NOAC use
  • Interrupted NOAC use
  • (no location specified)
Jul 20, 2021

Baseline Concentration of Direct Oral Anticoagulant and

Recruiting
  • Atrial Fibrillation
  • Anticoagulant-induced Bleeding
    • Cremona, Italy
      Sophie Testa
    Jul 19, 2022

    Mild Head Injury, Antiplatelets, and Anticoagulants

    Completed
    • Craniocerebral Trauma
    • Cerebral Hemorrhage
    • direct anticoagulant
    • +2 more
    • Roma, Rm, Italy
      Fondazione Policlinico Universitario Agostino Gemelli - IRCCS
    Mar 29, 2022

    Cancer Associated Thrombosis for Rivaroxaban - United States

    Completed
    • Treatment of Venous Thromboembolism in Cancer Patients
    • Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients
    • Rivaroxaban (Xarelto, BAY59-7939)
    • +2 more
    • Multiple Locations, Connecticut
      Many Locations
    May 18, 2022

    Association Between Genetic Variant Scores and DOACs (DARES2)

    Recruiting
    • Drug-Related Side Effects and Adverse Reactions
    • Iatrogenic Disorder
      • Seongnam-si, Gyonggi-do, Korea, Republic of
        SNUBH
      Jul 18, 2022

      Venous Thromboembolism Trial in France (Reduced dose of DOAC, Full dose of DOAC)

      Recruiting
      • Venous Thromboembolism
      • Reduced dose of DOAC
      • Full dose of DOAC
      • Amiens, France
      • +38 more
      Apr 21, 2022

      Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation Trial in Worldwide (P2Y12 inhibitor,

      Not yet recruiting
      • Percutaneous Coronary Intervention (PCI)
      • +3 more
      • P2Y12 inhibitor
      • +2 more
      • Hasselt, Belgium
      • +13 more
      Jul 25, 2023

      DOAC ADRs Retrospective Study

      Terminated
      • Drug-Related Side Effects and Adverse Reactions
        • San Jose, California
          Santa Clara Valley Medical Center
        Mar 4, 2021

        Anticoagulant-induced Bleeding Trial in Quebec (Warfarin, Dabigatran, Rivaroxaban)

        Not yet recruiting
        • Anticoagulant-induced Bleeding
        • Quebec, Canada
          Institut Universitaire de Cardiologie et de Pneumologie de Quebe
        Feb 17, 2021

        Ventricular Tachycardia, Premature Ventricular Contraction, Stroke Trial in India, United States (DOAC, Aspirin)

        Completed
        • Ventricular Tachycardia
        • +2 more
        • Kansas City, Kansas
        • +4 more
        Aug 30, 2021

        Specific PoC Testing of Coagulation in Patients Treated With

        Recruiting
        • Anticoagulation With NOAC
        • anti-Xa activity point-of-care testing (aXa-POCT)
        • ecarin clotting time point-of-care testing (ECT-POCT)
        • Tuebingen, Germany
          University Hospital Tuebingen
        Dec 14, 2020

        Classification Study for the TEG 6S System

        Completed
        • DOAC Eligible Subjects
        • TEG6s DOAC Cartridge
        • South Bend, Indiana
        • +3 more
        Feb 10, 2020

        Splanchnic Vein Thrombosis, Cerebral Vein Thrombosis, Ovarian Vein Thrombosis Trial in Varese (Direct Oral Anticoagulants)

        Unknown status
        • Splanchnic Vein Thrombosis
        • +4 more
        • Direct Oral Anticoagulants
        • Varese, Italy
          University of Insubria
        Apr 30, 2020

        Atrial Fibrillation Trial in Hamilton (PAUSE Perioperative DOAC Management, ASRA Perioperative DOAC Management)

        Unknown status
        • Atrial Fibrillation
        • PAUSE Perioperative DOAC Management
        • ASRA Perioperative DOAC Management
        • Hamilton, Ontario, Canada
        • +2 more
        Jan 20, 2020

        Interference Between Oral Anticoagulants and Heparin During

        Recruiting
        • Atrial Fibrillation
        • Atrial Tachycardia
          • Paris, France
            Hopital Bichat-Claude Bernard
          Mar 27, 2023

          Anticoagulant Therapy Trial in Mannheim (Apixaban 5 MG Tab, Dabigatran 150 MG Tab, Edoxaban 60Mg Tab)

          Active, not recruiting
          • Anticoagulant Therapy
          • Apixaban 5 MG Tab
          • +3 more
          • Mannheim, Germany
            Clincial Research Serivces
          Aug 4, 2022